Comparative efficacy and safety of donafenib versus bevacizumab in combination with immune checkpoint inhibitors and interventional therapy for advanced hepatocellular carcinoma: A retrospective ...
Across the industry, there are few benchmarks that customers and potential end users can employ to evaluate an inference acceleration solution end-to-end. Early on in this space, the performance of an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results